Morphine Sulfate Injection — FDA Drug Shortage

No longer listed by FDA — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Oct 31, 2017. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
No longer listed by FDA
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1892-01
Dosage Form
Injection
Presentation
Morphine Sulfate, Injection, 8 mg/1 mL Syringes (NDC 0409-1892-01)
Initial Posting
Oct 31, 2017

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.